Each week that the government is shutdown, the National Institutes of Health (NIH) will be turning away 200 patients. According to a piece in the Wall Street Journal, NIH director Francis Collins said, “About 200 patients who otherwise would be admitted to the NIH Clinical Center into clinical trials each week will be turned away.”1 An […]
It is with great sadness that we announce to the community the loss of two public figures who died this past week of malignant mesothelioma. Jocelyn Farrar, DNP was a member of our Board of Directors and widely known throughout the community for her work on behalf of mesothelioma patients, both raising awareness and […]
According to a report by the FDA, fluoroquinolones antibiotics now require new labeling to more adequately describe their most serious side-effect known as peripheral neuropathy.
Peripheral neuropathy is damage to nerves that initially presents itself as a tingling or shock sensation experienced in both the upper and lower extremities. It can cause a decrease in sensory […]
The World Trade Center (WTC) Health Program recently extended its coverage to include rescue, recovery, and clean-up workers who served at the Pentagon on September 11, 2001 during and after the terrorist attacks. The Program provides free medical screenings and treatment for health issues (including mesothelioma) related to exposures from the September 11th attacks.
The Pentagon […]
Last week, the Journal of Thoracic Oncology published the results of a study looking into the overexpression of the ephrin B2 receptor (EPHB2) in patients with mesothelioma. The researchers at the New York University Langone Medical Center observed that EPHB2 is overexpressed in all malignant mesothelioma cell lines, but not in benign mesothelial cells. In addition, […]